相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models
Lennart T. Mars et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
B. Venugopal et al.
CURRENT MEDICINAL CHEMISTRY (2011)
TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE
David J. Huss et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition
Zhifei Wang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
Michael Dickinson et al.
INVESTIGATIONAL NEW DRUGS (2010)
Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis
Nathan R. York et al.
JOURNAL OF AUTOIMMUNITY (2010)
Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon
Shella Saint Fleur et al.
BLOOD (2009)
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
Anneli Jaeger et al.
JOURNAL OF IMMUNOLOGY (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
ROMIDEPSIN FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
Clara Campas-Moya
DRUGS OF TODAY (2009)
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis
Honghong Sun et al.
CELL (2008)
Chronological changes of CD4+ and CD8+ T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
Yoshifumi Sonobe et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells
Hideaki Matsuoka et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1
Yufeng Shi et al.
NATURE IMMUNOLOGY (2007)
Histone deacetylase inhibitors for epigenetic therapy of cancer
Claude Monneret
ANTI-CANCER DRUGS (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
TGF-β:: a mobile purveyor of immune privilege
Sharon M. Wahl et al.
IMMUNOLOGICAL REVIEWS (2006)
Fas costimulation of naive CD4 T cells is controlled by NF-κB signaling and caspase activity
Mikael Maksimow et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Histone deacetylase inhibitors: discovery and development as anticancer agents
PA Marks et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice
AC Anderson et al.
JOURNAL OF IMMUNOLOGY (2004)
Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology
T Brunner et al.
SEMINARS IN IMMUNOLOGY (2003)
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2003)
Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy
L Massacesi
CLINICAL NEUROLOGY AND NEUROSURGERY (2002)
Apoptosis triggered by Myc-induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis
CM Eischen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
